Coronavirus Vaccine Developed In The U.S. Moves To Final Testing Phase

A potential coronavirus vaccine developed by U.S. biotech company Moderna and the National Institutes of Health started its final phase of testing Monday. The trial includes up to 30,000 volunteers.